Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine. (Q52046186)

20 April 2018

title

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine. (English)

1 reference

20 April 2018

0 references

Ma J

1

1 reference

20 April 2018

Hine PM

2

1 reference

20 April 2018

Clough ER

3

1 reference

20 April 2018

Fish D

4

1 reference

20 April 2018

Coughlin RT

5

1 reference

20 April 2018

Beltz GA

6

1 reference

20 April 2018

Shew MG

7

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 October 1996

1 reference

20 April 2018

published in

Vaccine

1 reference

20 April 2018

volume

14

1 reference

20 April 2018

issue

14

1 reference

20 April 2018

page(s)

1366-1374

1 reference

20 April 2018

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

1 reference

7 January 2021

Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Lyme disease-a tick-borne spirochetosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Reservoir competence of white-footed mice for Lyme disease spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete (Borrelia burgdorferi).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Borrelia burgdorferi and Babesia microti: efficiency of transmission from reservoirs to vector ticks (Ixodes dammini).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

The distribution of canine exposure to Borrelia burgdorferi in a Lyme-Disease endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

A perspective on the treatment of Lyme borreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Treating erythema chronicum migrans of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Passive immunization of hamsters against experimental infection with the Lyme disease spirochete

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Active immunization of hamsters against experimental infection with Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Experimental Lyme disease in dogs produces arthritis and persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Active immunization with pC protein ofBorrelia burgdorferi protects gerbils againstB. burgdorferi infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Antiborrelial activity of serum from rats injected with the Lyme disease spirochete

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

In Vitro Inhibition of Borrelia burgdorferi Growth by Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Approaches to augmenting the IgG antibody response to melanoma ganglioside vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Treatment of lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Immunoblot analysis of immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Cross immunity among types of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900045-X

7 January 2021

10.1016/S0264-410X(96)00045-X

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

9004447

1 reference

20 April 2018